Hikma And Celltrion Bolster Partnership To Expand Biosimilar Access In MENA Region
By Ron Chen, Bureau Chief, Asia The multinational pharmaceutical company, Hikma Pharmaceuticals PLC (Hikma), and its long-standing partner Celltrion Inc., a...
archivehikma
Hikma Posts A Stellar H1 Performance, Re-affirms Expectations For Strong Growth In The Second Half
By Ron Chen, Bureau Chief, Asia Hikma Pharmaceuticals Plc and its subsidiaries Hikma, the multinational pharmaceutical company, has reported its...
Hikma, IFC Pen US$250mn Deal, Marking A 40-year Partnership Driving Access To Quality Medicines In The MENA Region
By Ron Chen, Bureau Chief, Asia A multinational pharmaceutical company, Hikma Pharmaceuticals PLC (Hikma), and the International Finance Corporation (IFC), a...
Hikma Inks Exclusive Licensing Agreement With Pharma& To Bring Innovative Oncology Treatment To MENA Region
By Ron Chen, Bureau Chief, Asia The multinational pharmaceutical company, Hikma Pharmaceuticals PLC (Hikma), has announced an exclusive licensing agreement with...
Hikma Records Strong 2024 Performance And A Positive Outlook For 2025
By Ron Chen, Bureau Chief, Asia The multinational pharmaceutical company, Hikma Pharmaceuticals Plc today reports its audited results for the...
Hikma And M42 Pen Strategic MOU To Advance Healthcare Innovation In The UAE
By Ron Chen, Bureau Chief, Asia The multinational pharmaceutical group, Hikma Pharmaceuticals PLC (Hikma), today announces that it has signed...
